Clinical Characteristics of 34 Cases Diagnosed as Thymic Carcinoma in Our Institution-Reference-Cited by-同舟云学术

Clinical Characteristics of 34 Cases Diagnosed as Thymic Carcinoma in Our Institution

Published:2024-08-20 Issue:4 Volume:64 Page:283-289
ISSN:0386-9628
Container-title:Haigan
language:en
Short-container-title:JJLC

Author:

Kodama Yuta¹,Shirahige Aya¹,Matsuura Akihiko¹,Hiroshima Masao¹,Tsushima Yusuke¹,Yamada Yuuki¹,Tanaka Mari¹,Inagaki Masayasu¹,Takeyama Yoshihiro¹,Yokoyama Toshihiko¹

Affiliation:

1. Department of Respiratory Medicine, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital

Publisher

Japan Lung Cancer Society

Link

https://www.jstage.jst.go.jp/article/haigan/64/4/64_283/_pdf

Reference22 articles.

1. 1. Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, Kunkler I, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011; 47: 2493-2511.

2. 2. Hishida T, Nomura S, Yano M, Asamura H, Yamashita M, Ohde Y, et al. Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Datebase Study. Eur J Cardiothorac Surg. 2016; 49: 835-841.

3. 3. Sato J, Satouchi M, Itoh S, Okuma Y, Niho S, Mizugaki H, et al. Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial. Lancet Oncol. 2020; 21: 843-850.

4. 4. Ruffini E, Huang J, Cilento V, Goren E, Detterbeck F, Ahmad U, et al. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposal for a Stage Classification for the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol. 2023; 18: 1655-1671.

5. 5. Nakagawa K, Takahashi S, Endo M, Ohde Y, Kurihara H, Terauchi T. Can ¹⁸F-FDG PET predict the grade of malignancy in thymic epithelial tumors? An evaluation of only resected tumors. Cancer Manag Res. 2017; 9: 761-768.